Neurogenesis and Anti-Depression Actions - Annissa DeSilva
Santarelli
et al. and Bessa et al. both explore the neurogenic theory in the pathophysiology
of depression. This theory proposes that diminished neurogenesis in the hippocampus
may underlie the neural basis of depression. This theory is supported by a large
body of research that has found that chronic anti-depressant (AD) treatment
elicits neurogenesis in the hippocampus.
The
findings of Santerelli et al. further supported the neurogenic hypothesis
finding that treatment with AD’s after 28 days decreased latency to feed in the
novelty suppressed feeding (NSF) test and an increase of neurogenesis in the
dentate gyrus (determined by an increase in the number of BrDU labelled cells).
They conversely found that ablation of neurogenesis for 28 days through x-irradiation
in vehicle treated mice did not produce any depressive like behavior evidenced
by the NSF and chronic unpredictable stress (CUS) test (vehicle mice showed no effect
in latency to feed or groom). Santerelli et al. concluded that this finding was
still in line with the neurogenic hypothesis, speculating that a longer period
of ablation would produce behavioral deficits or that the neurons created due
to AD’s are different than cells produced before the introduction of AD’s. This
conclusion seems vague and highlights one of the main criticisms of the neurogenesis
hypothesis; decreased neurogenesis does not lead to depressive like behavior. Other
studies have come to similar conclusions, Surget, et al., 2008 found that
treatment of hippocampal irradiation had no effect on mice’s behavior in CUS
test. Jayatissa, et al., 2009 found similar results and concluded that the lack
of neurogenesis in irradiated mice is independent to the development of an anhedonia like
state. This data suggests that the deficits in neurogenesis observed in
depression model mice may be the result of a depressive state and not necessarily
involved in the etiology of the disorder.
Both papers, to some extent, agree
that in regard to the neurogenesis hypothesis that AD treatment increases neurogenesis
in the SGZ of the hippocampus, however Santerelli et al. makes broad assumptions
about the requirement of neurogenesis in AD action. However, it is unclear how proliferation
of new cells is specifically involved in the pathology of depression. Bessa et al. linked the therapeutic effects of AD treatment to specific neural remodeling
not neurogenesis.
The Bessa et al. findings paired with the findings of Jayatissa
et al., 2009 and Surget et al., 2008 suggest that neurogenesis although
effected by AD’s may not be implicated in depressive like behavior or treatment
of it. It would be interesting, if possible, to examine if AD’s have therapeutic
effects when different types of synaptic remodeling/plasticity is blocked. This would allow for further examination of what exact neural changes are producing therapeutic effects, if
any, or if synaptic plasticity is a “bi-product” of AD treatment similarly to neurogenesis.
Citations:
Surget, A., Saxe, M., Lemen, S., Ibarguen-Vargas, Y., Chalon, S., Griebel, G., . . . Belzung, C. (2008). Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversa. Biological Psychiatry,64(4), 293-301. doi:10.1016/j.biopsych.2008.02.022
Jayatissa, M. N., Henningsen, K., Nikolajsen, G., West, M. J., & Wiborg, O. (2009). A reduced number of hippocampal granule cells does not associate with an anhedonia-like phenotype in a rat chronic mild stress model of depression. Stress,13(2), 95-105. doi:10.3109/10253890902951786
This comment has been removed by the author.
ReplyDeleteSierra Smith- Research methods discrepancy and unanswered questions in Santarelli et al 2003
ReplyDeleteI think it's a very good catch that you highlight how x-irradiation in the Santarelli paper may have produced greater behavioral deficits following longer periods of ablation. Bessa et al 2009 draws attention to the fact that x-irradiation is a poor method for ablation due to the fact that it potentially causes significant inflammation effects, and may require an extended recovery period for reduced inflammation and lingering effects prior to beginning antidepressant treatment. This was the criteria that ultimately lead Bessa et al to use MAM as a means of chemically reducing neurogenesis without any confounding variables that may otherwise lead to hasty conclusions on the affects of antidepressant-treated ablated brains. Unfortunately, Santarelli et al do not seem to highlight any significant rest period of x-irradiated rodents prior to 28-day treatment course of antidepressants. I am concerned that the suppressed behavioral response to antidepressant treatment following x-ray ablation may be due to lingering inflammatory effects on the hippocampal connectivity instead of a true effect on the modulation of behavior through neurogenesis and antidepressant treatment.
Santarelli et al also choose to highlight data that seem to show little evidence to undeniably support their claim that hippocampal neurogenesis is required for the behavioral effects of antidepressants. Most of the evidence presented shows that either A. neurogenesis is actually occurring as a result of antidepressant treatment as shown by the increase in the number of BrdU-positive cells following at least 11 days of fluoxetine treatment, or B. antidepressants are effective in combating traditional behavioral symptoms of depression such as in latency to feed. Other than the x-irradiation study, which, as discussed, may incorporate flawed methodology, there seems to be a lack of evidence that there is actually a requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Bessa et al have a much stronger argument for neuroplasticity and synaptic remodeling being an essential component for these effects, as their chemical ablation method seems to be much more reliable in addition to the presentation of a more comprehensive and multi-faceted story. Their finding that the shift in types of dendritic spines from mushroom to thin spine under chronic mild stress conditions is particularly intriguing; it could be valuable to investigate this even further by using a radioactive or fluorescence tagged agent to visualize this shift in dendritic spine type under chemical ablation and antidepressant treatment conditions to build a more comprehensive story as to how synaptic remodeling may modulate these effects.